Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Drops By 60.0%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 200 shares, a decline of 60.0% from the February 29th total of 500 shares. Based on an average daily volume of 1,800 shares, the short-interest ratio is presently 0.1 days.

Lixte Biotechnology Stock Down 37.4 %

Shares of NASDAQ LIXTW traded down $0.03 during midday trading on Thursday, reaching $0.05. The company’s stock had a trading volume of 3,035 shares, compared to its average volume of 5,173. The business’s 50 day moving average price is $0.07 and its two-hundred day moving average price is $0.07. Lixte Biotechnology has a fifty-two week low of $0.03 and a fifty-two week high of $0.14.

Lixte Biotechnology Company Profile

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.